Physician

Renwick N Goldberg, MD

According to 2025 Medicare claims, Renwick Goldberg, MD (NPI: 1679566178) practices hematology/oncology in the Myrtle Beach-Conway-North Myrtle Beach, SC market, with the plurality of this provider's patient population coming from Horry, SC. This provider's primary affiliated billing organization is COASTAL CANCER CENTER LLC (NPI: 1881614170; TIN: 570777346) and primary practice location at 29572-4128.

Goldberg's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,529 traditional Medicare patients, billed 268,020 HCPCS/CPT codes, and received $5,711,834 in Medicare payments. The top billing code was 36415 (Insertion of needle into vein for collection of blood sample). Part D data shows 1,165 prescription claims across 203 beneficiaries totaling $4,252,957 in drug costs, led by Calquence (Acalabrutinib Maleate). DME data shows 33 claims. Open Payments data shows 9 records totaling $176. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have risen steadily, from $1,394,460 to $4,252,957. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $18,635 to $4,565.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,902	598,710	$4,709,159
2016	1,999	710,237	$6,347,768
2017	1,847	685,671	$6,267,757
2018	1,709	549,103	$5,471,747
2019	1,793	568,434	$6,014,461
2020	1,769	498,017	$6,268,486
2021	1,405	387,020	$5,178,562
2022	1,355	257,312	$4,102,799
2023	1,414	265,514	$4,385,719
2024	1,529	268,020	$5,711,834

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	333	1,599	$1,394,460
2016	360	1,819	$2,015,709
2017	323	1,792	$1,976,797
2018	308	1,582	$1,635,451
2019	276	1,644	$2,697,163
2020	266	1,485	$2,694,555
2021	252	1,399	$2,819,774
2022	248	1,295	$2,629,514
2023	230	1,314	$3,598,276
2024	203	1,165	$4,252,957

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	103	637	$103,355
2016	78	356	$62,065
2017	50	174	$31,060
2018	44	152	$13,899
2019	43	177	$15,390
2020	36	185	$16,640
2021	14	146	$8,788
2022	12	78	$4,549
2023	14	137	$18,306
2024	N/R	33	$3,174

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
36415	Insertion of needle into vein for collection of blood sample	927	2,817	$9
80076	Liver function blood test panel	848	2,024	$8
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	920	2,777	$8
82565	Blood creatinine level	848	2,034	$5
84520	Urea nitrogen level to assess kidney function, quantitative	848	2,035	$4

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Calquence	Acalabrutinib Maleate	74	2,220	$1,099,675
Lenalidomide	Lenalidomide	45	1,197	$597,198
Pomalyst	Pomalidomide	24	672	$569,664
Xtandi	Enzalutamide	30	900	$415,163
Revlimid	Lenalidomide	20	560	$386,304

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
L8000	Breast prosthesis, mastectomy bra, without integrated breast prosthesis form, any size, any type	N	N/R	22	$2,183
B4034	Enteral feeding supply kit; syringe fed, per day, includes but not limited to feeding/flushing syringe, administration set tubing, dressings, tape	N	N/R	11	$992

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	9	$176	Novartis Pharmaceuticals Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Renwick N. Goldberg, MD?

Tedicare shows public-source Medicare data for Renwick N. Goldberg, MD (NPI 1679566178), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Renwick N. Goldberg, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Renwick N. Goldberg, MD?

Renwick N. Goldberg, MD is linked to COASTAL CANCER CENTER LLC (billing NPI 1881614170) in the available physician profile data.

Does Renwick N. Goldberg, MD have Open Payments data?

Renwick N. Goldberg, MD has 9 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.